Replies to post #339787 on Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

"Fast Tract Designation clearly indicates that the FDA believes Brilacidin ..... success if very likely."

No it doesn't.

It indicates that FDA understand that there is a great need for a therapeutic to treat COVID-19. It doesn't speak to anything about whether or not FDA thinks brilacidin will be safe and/or effective for COVD-19

Doubtless they hope it will, just like the rest of us.

But hope is rarely a good investment strategy, especially when the company in question has a lying, incompetent, grasping clown as its CEO, as IPIX does.

[LilyGDog]

Justfactmam, today is another great day for IPIX share holders & humanity and I don't think that is an overstatement. Hopefully Leo sends us a Friday 4:00 pm press release to start the weekend.

What is Brilacidin worth if it brings the world back to equilibrium? Stay tuned to find out.

Is this a two press release week?

Go Leo & Brilacidin!

LilyGDog...you highlight the huge edge IPIX will have over (Non-fast-tract) therapy candidates...

...detractors of Leo won't admit it ... but Fast Tract Designation clearly indicates that the FDA believes Brilacidin (and possibly at the urging of a BP) success if very likely... an extremely positive development in Brilacidin..."coming out party"..

IMO even better news coming ... shortly! Look for "overseas" jurisdiction to give equivalent of "Fast Track" also!

Question about OWS..."Is fast track faster than OWS?"... OWS overlays Fast Track ... two run side by side.

Don't worry about the pennies...look at the dollars...and imo BP lurking and watching attentively...News will slowing spread for MOMO buildup...

ps. Sunspotter ...says..
Quote:
"Fast Tract Designation clearly indicates that the FDA believes Brilacidin ..... success if very likely."

No it doesn't. "


YES IT DOES...they ONLY GRANT FAST TRACT TO PROMISING DRUGS...not Dogsh*t which you have been indicating Brilacidin is.

Safety has been addressed...or didn't you notice we are in Phase 11! (not safety trials in Phase 1)